Real-Time M&A Intelligence for Life Sciences Companies

Explore the core tools that power Inflexion—from market-wide acquisition tracking to readiness scoring and board-ready reporting, built exclusively for life sciences.

Industry Insights

Market-wide acquisition intelligence with hyper-filterable dashboards and deal-level data. Analyze trends across the full life sciences M&A landscape—from deal size and timing to buyer behavior and market momentum.

Deal Size vs Stage Benchmarks

Visualize deal size distributions across development stages. Compare your target valuation against medians, and IQRs.

Market Attractiveness Analysis

Bubble charts mapping total deal value versus activity to identify high-value, high-momentum sectors and emerging opportunities.

Deal Momentum Tracking

Track year-over-year acquisition trends stacked by sector, stage and product type, spot momentum shifts and changing buyer behavior.

Advanced Transaction Database

Explore a comprehensive life sciences M&A database with granular filtering across deal structure, buyers, timing, and rationale.

Deal Density Heatmaps

Analyze where deals cluster across development stage and acquisition rationale to uncover market patterns and buyer intent.

Top Acquirer Intelligence

Top Acquirer rankings by sector, stage and product type. Identify the most active strategic buyers, how they transact, and which segments they prioritize.

User Insights

Profile-driven acquisition readiness assessment with real-time scoring, valuation benchmarking, top acquirer identification, and exit timing signals based on similar companies’ exit paths. Intelligence tailored to your company.

Acquisition Readiness Score

Real-time composite score based on your company profile and market signals. Track readiness over time and understand key drivers.

Top Potential Acquirers

Ranked list of acquirers most active in buying companies like yours, scored by strategic fit and recent deal activity.

Valuation Range Benchmarking

Median, top quartile, and bottom quartile exit values from comparable acquisitions. Validate your target valuation against market reality.

Similar Companies Analysis

Proximity-scored table of comparable exits with full deal details. Export to CSV for your own deeper analysis.

Historical Exit Timelines

Stage-specific exit timing visualizations showing valuation ranges and deal windows. Understand when similar companies typically get acquired.

Market Momentum Indicators

Year-over-year acquisition growth in your sector and stage, with signals on market momentum, readiness, and timing.

Board Deck Generator

Auto-generate a board-ready M&A narrative that synthesizes market intelligence, readiness assessment, valuation context, and strategic recommendations—structured for executive and board-level discussion.

Executive Summary

Five-point narrative linking market conditions, acquisiton readiness, valuation context, buyer landscape, and recommended actions.

Market Context & Timing

Sector-specific charts with commentary on deal signals, trends, and what they mean for your positioning and timing.

Acquisition Readiness Report

Summary of your current acquisition readiness, key drivers, and priority focus areas over the next 12–18 months.

Buyer Landscape & Strategic Fit

Overview of the most relevant strategic buyers, their recent activity, strategic rationale, and implications for positioning and outreach.

Valuation Context & Comparables

Valuation benchmarks from comparable exits, with narrative context on where your target sits relative to recent transactions.

Strategic Outlook & Board Actions

One-page strategic outlook outlining market window, readiness priorities, and recommended board-level actions over the next 12–18 months.

See Inflexion in action

Get started today and access comprehensive M&A intelligence for the medical device and life sciences sector.